本文翻译正在准备中。在此之前，我们暂时显示英文原文。
商业 · 2007/3/91 分钟阅读
Implantation or Injectable Dosage Form New Animal Drugs; Enrofloxacin
本地自动翻译 · 来源原始语言
摘要
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Bayer HealthCare LLC. The supplemental NADA provides for changing scientific nomenclature for a bovine respiratory pathogen on labeling for enrofloxacin injectable solution.
来源原始语言: Federal Register — Food and Drug Administration打开原始公告 →